UPB vs VNO · rev $2.9M vs rev $921.3M
Upstream Bio, Inc. (UPB) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
UPB currently screens at market cap $407.3M. VNO currently screens at market cap $0.
Not investment advice. Open the UPB and VNO stock pages for the full models.
Not investment advice.